Bezoar formation is cited to be the cause of delayed absorption of aspirin in overdose of enteric-coated aspirin preparation. However, such phenomenon from oral overdose of regular aspirin preparation has not been clearly demonstrated in human. The use of multiple-dose activated charcoal (MDAC) in salicylate poisoning remains controversial. We report a case of regular-preparation salicylate poisoning with rebound of the serum salicylate level after discontinuation of MDAC administration. Bezoar formation as the underlying cause of the rebound and the effect of MDAC on serum salicylate level are discussed.
ThistedB., KrantzT., StrøomJ., SørensenM.B.Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesthesiol Scand1987; 31(4): 312–6.
2.
McGuiganM.A.A two-year review of salicylate deaths in Ontario. Arch Intern Med1987; 147(3): 510–2.
3.
YipL., DartR.C., GabowP.A.Concepts and controversies in salicylate toxicity. Emerg Med Clin North Am1994; 12(2): 351–64.
4.
American Academy of Clinical Toxicology; European Association of Poisons Control Centres and Clinical Toxicologists. Position Statement and practice guidelines on the use of multiple-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol1999; 37(6): 731–51.
5.
StackP.E., ThomasE.Pharmacobezoar: an evolving new entity. Dig Dis1995; 13(6): 356–64.
6.
SoggeM.R., GriffithJ.L., SinarD.R., MayesG.R.Lavage to remove enteric-coated aspirin and gastric outlet obstruction. Ann Intern Med1977; 87(6): 721–2.
7.
SpringerD.J., GrollA.Poisoning with enteric-coated acetylsalicylic acid complicating gastric outlet obstruction. Can Med Assoc J1980; 122(9): 1032–4.
8.
WiseC.M., OwenD.S.Jr, JesseeE.F.JrAnother case of salicylate intoxication with enteric coated aspirin: association with gastric outlet obstruction. J Rheumatol1982; 9(3): 482–3.
9.
BogaczA., CaldronP.Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management. Am J Med1987; 83(4): 783–6.
10.
ToddP.J., SillsJ.A., HarrisF., CowenJ.M.Problems with overdoses of sustained-release aspirin. Lancet1981; 1(8223): 777.
11.
KwongT.C., LaczinJ., BaumJ.Self-poisoning with enteric-coated aspirin. Am J Clin Pathol1983; 80(6): 888–90.
12.
PierceR.P., GazewoodJ., BlakeR.L.JrSalicylate poisoning from enteric-coated aspirin. Delayed absorption may complicate management. Postgrad Med1991; 89(5): 61–2, 64.
13.
WortzmanD.J., GrunfeldA.Delayed absorption following enteric-coated aspirin overdose. Ann Emerg Med1987; 16(4): 434–6.
14.
RiveraW., KleinschmidtK.C., VelezL.I., ShepherdG., KeyesD.C.Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother 2004; 38(7-8): 1186-8. Erratum in: Ann Pharmacother2006; 40(5): 999.
EpplerJ., JohnsonD., VerjeeZ., GiesbrechtE., ItoS.Measurement of serum acetylsalicylic acid in a porcine model of aspirin overdose. Vet Hum Toxicol1996; 38(6): 409–12.
17.
DargonP.I., WallaceC.I., JonesA.L.An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J2002; 19(3): 206–9.
18.
HaydenJ.W., ComstockE.G.Use of activated charcoal in acute poisoning. Clin Toxicol1975; 8(5): 515–33.
19.
LevyG., TsuchiyaT.Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther1972; 13(3): 317–22.
20.
MontgomeryP.R., BergerL.G., MitenkoP.A., SitarD.S.Salicylate metabolism: effects of age and sex in adults. Clin Pharmacol Ther1986; 39(5): 571–6.
21.
LevyG.Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med1982; 307(11): 676–8.
22.
BergM.J., BerlingerW.G., GoldbergM.J., SpectorR., JohnsonG.F.Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med1982; 307(11): 642–4.
23.
BerlingerW.G., SpectorR., GoldbergM.J., JohnsonG.F., QueeC.K., BergM.J.Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther1983; 33(3): 351–4.
24.
JohnsonD., EpplerJ., GiesbrechtE., VerjeeZ., RaisA., WigginsT.Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med1995; 26(5): 569–74.
25.
HillmanR.J., PrescottL.F.Treatment of salicylate poisoning with repeated oral charcoal. Br Med J (Clin Res Ed)1985; 291(6507): 1472.
26.
BaroneJ.A., RaiaJ.J., HuangY.C.Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med1988; 17(1): 34–7.
27.
HoJ.L., TierneyM.G., DickinsonG.E.An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination. J Clin Pharmacol1989; 29(4): 366–9.
MayerA.L., SitarD.S., TenenbeinM.Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate. Arch Intern Med1992; 152(2): 393–6.
30.
NeuvonenP.J., ElfvingS.M., ElonenE.Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol1978; 13(3): 213–8.
31.
FillipponeG.A., FishS.S., LacoutureP.G., ScavoneJ.M., LovejoyF.H.JrReversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med1987; 147(8): 1390–2.
